Brookline, MA, United States of America

Sridhar Ramaswamy

This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., Whitehead Institute for Biomedical Research. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sridhar Ramaswamy. Retrieved from https://idiyas.com/inventor/sridhar-ramaswamy-mxf2f3nb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sridhar Ramaswamy

Introduction

Sridhar Ramaswamy is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of cancer diagnostics. His work focuses on the identification of genetic markers that can aid in the diagnosis and treatment of tumors.

Latest Patents

Ramaswamy holds a patent for "Genetic markers for tumors." This patent describes sets of genetic markers for specific tumor classes, as well as methods for identifying biological samples based on these markers. The patent also outlines diagnostic, prognostic, and therapeutic screening uses for these markers, along with oligonucleotide arrays that comprise these markers. He has 1 patent to his name.

Career Highlights

Throughout his career, Ramaswamy has worked with prestigious institutions such as the Whitehead Institute for Biomedical Research and Dana-Farber Cancer Institute. His research has significantly advanced the understanding of tumor biology and has implications for personalized medicine.

Collaborations

Ramaswamy has collaborated with esteemed colleagues, including Todd R. Golub and Pablo Tamayo. Their joint efforts have contributed to the development of innovative approaches in cancer research.

Conclusion

Sridhar Ramaswamy's work in identifying genetic markers for tumors represents a significant advancement in cancer diagnostics and treatment. His contributions continue to influence the field of biomedical research and offer hope for improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…